BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6662670)

  • 1. Virus-specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection.
    Friedman M; Hadari I; Goldstein V; Sarov I
    Isr J Med Sci; 1983 Oct; 19(10):881-4. PubMed ID: 6662670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific IgA in serum, saliva, and tears of children with measles.
    Friedman MG; Phillip M; Dagan R
    Clin Exp Immunol; 1989 Jan; 75(1):58-63. PubMed ID: 2495200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay.
    Perry KR; Brown DW; Parry JV; Panday S; Pipkin C; Richards A
    J Med Virol; 1993 Jul; 40(3):235-40. PubMed ID: 8355022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific IgM antibodies in the saliva of mumps patients.
    Franková V; Sixtová E
    Acta Virol; 1987 Aug; 31(4):357-64. PubMed ID: 2892386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey on antibodies against measles virus and mumps virus in sera of children in Beijing].
    Dai YH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Jul; 17(4):224-5. PubMed ID: 6641417
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunoassay for the detection of virus-specific IgA antibodies in saliva.
    Friedman MG
    J Immunol Methods; 1982 Oct; 54(2):203-11. PubMed ID: 6184413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
    Garrido Redondo M; Blanco Quirós A; Garrote Adrados JA; Tellería Orriols JJ; Arranz Sanz E
    An Esp Pediatr; 1997 Nov; 47(5):499-504. PubMed ID: 9586291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.
    El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL
    J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to acute otitis media in children III. Implications of viral antibody in middle ear fluid.
    Sloyer JL; Howie VM; Ploussard JH; Bradac J; Habercorn M; Ogra PL
    J Immunol; 1977 Jan; 118(1):248-50. PubMed ID: 187700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serological evidence for mumps virus infection in vaccinated children.
    Dittrich S; Hahné S; van Lier A; Kohl R; Boot H; Koopmans M; van Binnendijk R
    Vaccine; 2011 Nov; 29(49):9271-5. PubMed ID: 21983156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Virus-specific IgM proof with routine serologic methods (author's transl)].
    Doerr HW; Fretschner R; Geisen HP
    Zentralbl Bakteriol A; 1980 Mar; 246(2):158-66. PubMed ID: 6252719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.